Orthofix Launches Trinity® ELITE™ Moldable Bone Graft

TrinityElite moldable bone graftOrthofix International N.V., in collaboration with the Musculoskeletal Transplant Foundation (MTF), has announced the full market release of Trinity® ELITE™ Allograft with Viable Cells and VersaShield™ Amniotic Membrane tissue forms.


Trinity ELITE, a third generation allograft with viable cells, provides surgeons with a unique alternative to autograft, the standard for bone grafting. Orthofix says it builds on the exemplary safety profile of more than 75,000 Trinity Evolution® procedures. Trinity ELITE provides a viable grafting alternative and possesses the unique feature of being fully moldable by the user, a key distinction of the proprietary technology that MTF developed.

The full market release of Trinity ELITE includes the launch into both spinal and extremity applications and is available in four different quantities. The product will be made available  through Orthofix’s Spine Fixation and U.S. Extremity Fixation distribution channels.

Physician comments

Dr. Peter M. Shedden, MSc., M.D., FRCS(C), FACS, FAANS, of the Greater Houston Neurosurgery Center in The Woodlands, Texas and a member of the Company’s medical education team, stated, “In my initial usage of Trinity ELITE, I have been extremely satisfied with the ability to pack more graft material into a disc space during a posterior lumbar interbody fusion procedure, as well as postero-laterally. In addition, this novel allograft represents a new option for surgeons who want to apply a cell-based allograft to the lateral gutter and lay it flat along the transverse process.”

Company comments 

Orthofix President and Chief Executive Officer Brad Mason noted, “We are very excited about the initial feedback from the early adopters, which has been universally and extremely positive, as it confirms Trinity ELITE overcomes current challenges in graft containment and handling of cell-based tissue forms. Orthofix has long maintained its commitment to co-developing and commercializing such exciting technology with MTF, and we plan to continue being innovators in this space.”

Chief Executive Officer of the Musculoskeletal Transplant Foundation Bruce Stroever commented, “Over the last five years, the MTF/Orthofix partnership has proven to be a successful endeavor providing a new, viable cell tissue form to tissue recipients. We are pleased to release our newest innovation, Trinity ELITE. Trinity ELITE is the first fully moldable allograft with viable cells. This next generation allograft is the first cell-based offering of its kind designed to provide an enhanced handling experience and greatly improved graft containment properties.”

Source: Orthofix International , N.V., Business Wire